| 291 | Novel therapeutic targets for pancreatic cancer |
| 292 | Pancreatic cancer-improved care achievable |
| 293 | Pancreatic cancer: Advances in treatment |
| 294 | Neoadjuvant strategies for pancreatic cancer |
| 295 | Therapeutic applications of curcumin for patients with pancreatic cancer |
| 296 | Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression |
| 297 | Role of non-coding RNAs in pancreatic cancer: The bane of the microworld |
| 298 | Establishment of an orthotopic pancreatic cancer mouse model: Cells suspended and injected in Matrigel |
| 299 | Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer |
| 300 | 异常黑胆质型肝癌病证动物模型肝硬化期肝脏中p53、p21、STAT3和Cyclin D1基因的表达 |
| © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |